Swimmer's Ear Treatments
Find Swimmer's Ear Treatments
Medications for Swimmer's Ear
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Swimmer's Ear.
Found 3 Approved Drugs for Swimmer's Ear
Ofloxacin
Brand Names
Ocuflox, Ofloxacin Ophth, Olfoxacin
Ofloxacin
Brand Names
Ocuflox, Ofloxacin Ophth, Olfoxacin
Form: Tablet, Solution
Method of administration: Auricular (otic), Oral, Ophthalmic
FDA approval date: August 01, 1993
Classification: Quinolone Antimicrobial
OCUFLOX ® ophthalmic solution is indicated for the treatment of infections caused by susceptible strains of the following bacteria in the conditions listed below: *Efficacy for this organism was studied in fewer than 10 infections CONJUNCTIVITIS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Enterobacter cloacae Staphylococcus epidermidis Haemophilus influenzae Streptococcus pneumoniae Proteus mirabilis Pseudomonas aeruginosa CORNEAL ULCERS: Gram-positive bacteria: Gram-negative bacteria: Staphylococcus aureus Pseudomonas aeruginosa Staphylococcus epidermidis Serratia marcescens* Streptococcus pneumoniae Anaerobic species: Propionibacterium acnes.
Fluocinolone Acetonide
Brand Names
Derma-Smoothe, Dermotic, Flac, Iluvien, Neo-Synalar, Retisert, Synalar, YUTIQ
Fluocinolone Acetonide
Brand Names
Derma-Smoothe, Dermotic, Flac, Iluvien, Neo-Synalar, Retisert, Synalar, YUTIQ
Form: Ointment, Cream, Oil, Implant, Solution
Method of administration: Auricular (otic), Intravitreal, Topical
FDA approval date: June 11, 1963
Classification: Corticosteroid
INDICATION AND USAGE Derma-Smoothe/FS ® is a low to medium potency corticosteroid indicated: In adult patients for the treatment of psoriasis of the scalp (Scalp Oil).
XTORO
Generic Name
Finafloxacin
XTORO
Generic Name
Finafloxacin
Form: Suspension
Method of administration: Auricular (otic)
FDA approval date: March 24, 2026
Classification: Quinolone Antimicrobial
XTORO® is indicated for the treatment of acute otitis externa (AOE) with or without an otowick, caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus in patients age 1 year and older. XTORO® is a quinolone antimicrobial indicated for the treatment of acute otitis externa (AOE) caused by susceptible strains of Pseudomonas aeruginosa and Staphylococcus aureus. ( 1 )
Showing 1-3 of 3
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances